Cargando…
Correction to Epac‐2 ameliorates spontaneous colitis in Il‐10 (−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623513/ https://www.ncbi.nlm.nih.gov/pubmed/37608760 http://dx.doi.org/10.1111/jcmm.17885 |
Ejemplares similares
-
Epac‐2 ameliorates spontaneous colitis in Il‐10
(−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
por: Song, Xue, et al.
Publicado: (2021) -
Corrigendum to “Suppressing Syndecan-1 Shedding Ameliorates Intestinal Epithelial Inflammation through Inhibiting NF-κB Pathway and TNF-α”
por: Zhang, Yan, et al.
Publicado: (2017) -
Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
por: Chen, Xiao-Wen, et al.
Publicado: (2016) -
Corrigendum to “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways”
por: Hsia, Chih-Hsuan, et al.
Publicado: (2022) -
Bryostatin‐1 ameliorated experimental colitis in Il‐10
(−/−) Mice by protecting the intestinal barrier and limiting immune dysfunction
por: Zuo, Lugen, et al.
Publicado: (2019)